{"id":90120,"date":"2026-11-17T16:00:39","date_gmt":"2026-11-17T07:00:39","guid":{"rendered":"https:\/\/www.waseda.jp\/top\/en\/?p=90120"},"modified":"2026-11-17T23:00:30","modified_gmt":"2026-11-17T14:00:30","slug":"%ef%bc%88%e4%bd%9c%e6%a5%ad%e4%b8%ad%ef%bc%89taking-an-innovative-acl-reconstruction-technique-to-the-world","status":"publish","type":"post","link":"https:\/\/www.waseda.jp\/top\/en\/news\/90120","title":{"rendered":"Taking an Innovative ACL Reconstruction Technique to the World"},"content":{"rendered":"<p>Professor Kiyotaka Iwasaki of Waseda University\u2019s Faculty of Science and Engineering is developing a \u201ctissue-regenerative ligament\u201d for anterior cruciate ligament (ACL) reconstruction and working toward its practical application. In August 2024, the Clinical Trial Notification was accepted by Japan\u2019s Pharmaceuticals and Medical Devices Agency (PMDA), and the clinical trial began at Tokyo Women\u2019s Medical University in November. How did Professor Iwasaki develop a technology with the potential to transform sports medicine? This article traces the story behind its development.<\/p>\n<h1 style=\"margin: 10.0pt 0mm 5.0pt 0mm;\"><span lang=\"EN-US\">Challenges Facing Athletes with Ligament Injuries and the Limitations of Current Medical Care<\/span><\/h1>\n<p>Anterior cruciate ligament injuries occur in many sports. Approximately 19,000 ACL reconstruction procedures are performed each year in Japan and 175,000 in the United States. The high risk of reinjury after treatment remains a serious concern for athletes. Professor Kiyotaka Iwasaki of Waseda University\u2019s Faculty of Science and Engineering is working to address this challenge.<\/p>\n<div id=\"attachment_90165\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-90165\" src=\"https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/01_N7A4918-scaled.jpg\" alt=\"Professor Kiyotaka Iwasaki\" width=\"2560\" height=\"1707\" srcset=\"https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/01_N7A4918-scaled.jpg 2560w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/01_N7A4918-610x407.jpg 610w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/01_N7A4918-2000x1333.jpg 2000w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/01_N7A4918-768x512.jpg 768w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/01_N7A4918-1536x1024.jpg 1536w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/01_N7A4918-2048x1365.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><p class=\"wp-caption-text\">Professor Kiyotaka Iwasaki (Cooperative Major in Advanced Biomedical Sciences, Graduate School of Advanced Science and Engineering, Faculty of Science and Engineering). He is the founder and Chief Technology Advisor of CoreTissue BioEngineering, Inc.<\/p><\/div>\n<p>\u201cThe anterior cruciate ligament in the knee is an important structure connecting the femur and tibia. When it is injured, athletes undergo reconstruction surgery in order to return to competition. However, with the current standard of care, it is difficult to eliminate the risk of reinjury after surgery. This reflects the limitations of conventional treatment.\u201d<\/p>\n<p>In ACL reconstruction, a substitute tissue known as a graft is secured in bone tunnels created in the femur and tibia. The graft is generally made from another tissue harvested from the patient\u2019s own body, but Professor Iwasaki explains that this approach presents several challenges.<\/p>\n<p>\u201cThe most commonly used graft materials are the hamstring tendon, located at the back of the thigh, and the patellar tendon harvested with small bone blocks attached. A thick tendon is needed to reduce the risk of postoperative graft failure, and a diameter of at least 8 mm is widely regarded as an important benchmark. However, hamstring tendons are relatively thin and vary from person to person. Even when folded into four strands, they are often less than 8 mm in diameter. Harvesting the hamstring tendon can also cause nerve injury or reduced muscle strength. With patellar tendon grafts, anterior knee pain may persist after surgery and knee-extension function may be impaired. In cases involving injuries to multiple ligaments, there may simply be insufficient tendon available for harvesting. Nevertheless, autograft reconstruction remains the approach used in almost all cases in Japan because there is currently no established alternative.\u201d<\/p>\n<div id=\"attachment_90166\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-90166\" src=\"https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/02_5e4896966c9944fcf00890f4502605bf-1.png\" alt=\"Location of the anterior cruciate ligament (left) and an illustration of the graft (right)\" width=\"495\" height=\"617\" \/><p class=\"wp-caption-text\">Location of the anterior cruciate ligament (left) and an illustration of the graft (right). A hamstring tendon graft is folded into four strands, but its average diameter is only 7.4 mm.<\/p><\/div>\n<h1 style=\"margin: 10.0pt 0mm 5.0pt 0mm;\"><span lang=\"EN-US\">Developing a Thick, Strong Reconstruction Graft Using a World-First Decellularization Technology<\/span><\/h1>\n<p>Professor Iwasaki approached these challenges from an entirely new direction: using animal tissue rather than the patient\u2019s own tissue. His team set out to create a reconstruction graft from bovine tendon.<\/p>\n<p>\u201cMammals share broadly similar structural components, including collagen, and bovine tendons have sufficient thickness. However, transplanting them as they are would trigger inflammatory and other immune reactions, so the cells must first be removed from the bovine tissue. We therefore adopted a process known as decellularization.\u201d<\/p>\n<p>Professor Iwasaki\u2019s decellularization technology removes cellular components from within the tissue without destroying its structural framework. Decellularization had existed since the late 1990s, but it was largely limited to thin membranes measuring no more than about 1 mm. Moreover, the solutions used to lyse cells could also damage the collagen structure. The technology therefore had to be advanced so that the graft could retain mechanical strength comparable to that of a human ligament.<\/p>\n<p>\u201cOur first idea was to apply microwaves, as in a microwave oven, to make water molecules vibrate. At 2.45 billion oscillations per second and a processing temperature below 37\u00b0C, the cell-membrane lysis solution can penetrate deep into thick tissue. We also introduced a system that circulates the solution through pulsatile flow and pressure. The inspiration came from the way the beating heart circulates blood throughout the body. We have obtained international patents for these two technologies, which reduce residual DNA to a level that meets safety criteria.\u201d<\/p>\n<div id=\"attachment_90167\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-90167\" src=\"https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/03_N7A4995-scaled-1.jpg\" alt=\"Equipment used in Professor Iwasaki\u2019s decellularization process.\" width=\"2560\" height=\"1707\" srcset=\"https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/03_N7A4995-scaled-1.jpg 2560w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/03_N7A4995-scaled-1-610x407.jpg 610w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/03_N7A4995-scaled-1-2000x1334.jpg 2000w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/03_N7A4995-scaled-1-768x512.jpg 768w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/03_N7A4995-scaled-1-1536x1024.jpg 1536w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/03_N7A4995-scaled-1-2048x1366.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><p class=\"wp-caption-text\">Equipment used in Professor Iwasaki\u2019s decellularization process. While microwaves are applied to the tendon housed in the central chamber, a pulsatile pump delivers lysis solution through the tubing into the chamber, removing cellular components from the tissue.<\/p><\/div>\n<p>Sterilization is also essential after the cells have been removed. Killing microorganisms without damaging the tissue is a major challenge in medical-device development. Gamma irradiation can degrade collagen, so the tissue must instead be freeze-dried and sterilized with ethylene oxide gas (EOG). The problem is that conventionally freeze-dried tissue does not readily rehydrate even when immersed in water. Professor Iwasaki needed to find a solution.<\/p>\n<p>\u201cThe clue came from the sleeping chironomid, an organism that enters a dormant state during droughts in the African desert. We learned that it contains a distinctive sugar not found in most other organisms and decided to test it. By immersing the tissue in an appropriate concentration of sugar solution before freeze-drying, we were able to protect its mechanical strength and successfully restore it to a hydrated state after sterilization.\u201d<\/p>\n<div id=\"attachment_90168\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-90168\" src=\"https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/04_N7A5002-scaled.jpg\" alt=\"The drying process. The team found that pretreatment in a sugar solution protects the tissue during both freeze-drying and EOG sterilization. This technology has also been patented internationally.\" width=\"2560\" height=\"1707\" srcset=\"https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/04_N7A5002-scaled.jpg 2560w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/04_N7A5002-610x407.jpg 610w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/04_N7A5002-2000x1333.jpg 2000w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/04_N7A5002-768x512.jpg 768w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/04_N7A5002-1536x1024.jpg 1536w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/04_N7A5002-2048x1365.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><p class=\"wp-caption-text\">The drying process. The team found that pretreatment in a sugar solution protects the tissue during both freeze-drying and EOG sterilization. This technology has also been patented internationally.<\/p><\/div>\n<h1 style=\"margin: 10.0pt 0mm 5.0pt 0mm;\"><span lang=\"EN-US\">Commercializing a Self-Remodeling \u201cTissue-Regenerative Ligament\u201d through a University Startup<\/span><\/h1>\n<p>The resulting decellularized tendon achieved mechanical strength comparable to that of human hamstring and patellar tendons. Human donor tissue is often too thin because of differences in body size and anatomy, but the new medical device combines the required thickness with high mechanical strength. Repeated animal studies conducted in preparation for practical application also demonstrated important biological properties.<\/p>\n<p>\u201cWe performed ACL reconstruction in 56 sheep using either decellularized bovine tendon grafts or the sheep\u2019s own tendons and compared the outcomes at approximately three months and one year. In the decellularized tendon group, the reconstructed tissue became firmly integrated with the bone. We also found that collagen density was higher at one year than at three months. This indicates that the sheep\u2019s own cells had infiltrated the graft and begun regenerating functional tissue. Its defining advantage is excellent biocompatibility, something that cannot be achieved with synthetic materials.\u201d<\/p>\n<p>Firm bone integration and increased collagen density dramatically improve the stability of reconstructed tissue. By removing the cells while preserving the extracellular tissue architecture, the team created a \u201ctissue-regenerative ligament\u201d that can serve as a scaffold for the body\u2019s own tissue remodeling.<\/p>\n<div id=\"attachment_90169\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-90169\" src=\"https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/05_N7A4991-scaled-1.jpg\" alt=\"The decellularized tendon under development\" width=\"2560\" height=\"1707\" srcset=\"https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/05_N7A4991-scaled-1.jpg 2560w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/05_N7A4991-scaled-1-610x407.jpg 610w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/05_N7A4991-scaled-1-2000x1334.jpg 2000w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/05_N7A4991-scaled-1-768x512.jpg 768w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/05_N7A4991-scaled-1-1536x1024.jpg 1536w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/05_N7A4991-scaled-1-2048x1366.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><p class=\"wp-caption-text\">The decellularized tendon under development. It retains the elasticity and extensibility of biological tissue, while its clean white appearance gives little indication that it is animal-derived.<\/p><\/div>\n<p>\u201cIf this technology can be applied in humans, the graft should gradually be replaced by the patient\u2019s own ligament tissue inside the body. In a very literal sense, it will undergo \u2018ligamentization\u2019 and become integrated into the human body. To bring this world-first therapeutic device to patients, we established CoreTissue BioEngineering in 2016.\u201d<\/p>\n<p>Since the company\u2019s establishment, CoreTissue BioEngineering has worked toward commercialization with support from the Japan Agency for Medical Research and Development (AMED), conducting preclinical research to evaluate safety and performance before application in humans. In August 2024, the Clinical Trial Notification submitted to the Pharmaceuticals and Medical Devices Agency (PMDA), under Japan\u2019s Ministry of Health, Labour and Welfare, was accepted. The clinical trial began at Tokyo Women\u2019s Medical University in November, and was scheduled to expand to six sites across Japan.<\/p>\n<p>\u201cAfter completing the clinical trial, the next step will be full-scale implementation. An estimated 800,000 patients worldwide require surgery for ACL injuries each year. We also believe that this technology could be applied to tendon and ligament injuries of the shoulder, elbow, and ankle. If we can steadily grow the business within this vast market, we may be able to bring meaningful innovation to sports medicine.\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-90170\" src=\"https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/06_N7A4960-scaled-1.jpg\" alt=\"CoreTissue BioEngineering is currently establishing its production system and raising capital in preparation for implementation.\" width=\"2560\" height=\"1707\" srcset=\"https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/06_N7A4960-scaled-1.jpg 2560w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/06_N7A4960-scaled-1-610x407.jpg 610w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/06_N7A4960-scaled-1-2000x1334.jpg 2000w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/06_N7A4960-scaled-1-768x512.jpg 768w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/06_N7A4960-scaled-1-1536x1024.jpg 1536w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/06_N7A4960-scaled-1-2048x1366.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/p>\n<p class=\"CaptionCustom\" style=\"margin-bottom: 6.0pt; line-height: 107%;\"><span lang=\"EN-US\">CoreTissue BioEngineering is currently establishing its production system and raising capital in preparation for implementation.<\/span><\/p>\n<h1 style=\"margin: 10.0pt 0mm 5.0pt 0mm;\"><span lang=\"EN-US\">Contributing to Athletes Worldwide by Advancing Reconstructive Surgery<\/span><\/h1>\n<p>Professor Iwasaki is taking on the challenge of building a venture business around a world-first technology. What has motivated him to carry the project forward? We concluded by asking him about the commitment behind his research.<\/p>\n<p>\u201cFrom my undergraduate years in Waseda University\u2019s School of Science and Engineering through the completion of my doctoral dissertation, I studied heart valves for use in artificial hearts. I then began researching decellularized tissues because I wanted to create therapeutic devices that would regenerate in the body and continue functioning for a lifetime. Later, researchers in sports medicine told me about the problems surrounding ligament reconstruction. Wanting to take on an unprecedented challenge, I began research on ligaments. I also enjoy sports myself, so I understand how important a stable ligament is. For athletes and everyone who participates in sports, a stable, functional knee without the burden of harvesting their own tissue, and the prospect of returning to activity even after repeated injury, would offer irreplaceable value.<\/p>\n<p>\u201cNothing would make me happier than for this technology to relieve the concerns of as many people as possible and help them live fuller lives.\u201d<\/p>\n<div id=\"attachment_90171\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-90171 size-full\" src=\"https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/07_N7A5037-scaled-1.jpg\" alt=\"Photo of Professor\" width=\"2560\" height=\"1707\" srcset=\"https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/07_N7A5037-scaled-1.jpg 2560w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/07_N7A5037-scaled-1-610x407.jpg 610w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/07_N7A5037-scaled-1-2000x1334.jpg 2000w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/07_N7A5037-scaled-1-768x512.jpg 768w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/07_N7A5037-scaled-1-1536x1024.jpg 1536w, https:\/\/www.waseda.jp\/top\/en\/assets\/uploads\/2026\/11\/07_N7A5037-scaled-1-2048x1366.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><p class=\"wp-caption-text\">Photo Credit: Waseda University Center for Advanced Biomedical Sciences (TWIns)<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Professor Kiyotaka Iwasaki of Waseda University\u2019s Faculty of Science and Engineering is developing a \u201ctissue-r [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":90177,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[81,117],"tags":[178],"class_list":["post-90120","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-topic","tag-research-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.waseda.jp\/top\/en\/wp-json\/wp\/v2\/posts\/90120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.waseda.jp\/top\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.waseda.jp\/top\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.waseda.jp\/top\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.waseda.jp\/top\/en\/wp-json\/wp\/v2\/comments?post=90120"}],"version-history":[{"count":2,"href":"https:\/\/www.waseda.jp\/top\/en\/wp-json\/wp\/v2\/posts\/90120\/revisions"}],"predecessor-version":[{"id":90173,"href":"https:\/\/www.waseda.jp\/top\/en\/wp-json\/wp\/v2\/posts\/90120\/revisions\/90173"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.waseda.jp\/top\/en\/wp-json\/wp\/v2\/media\/90177"}],"wp:attachment":[{"href":"https:\/\/www.waseda.jp\/top\/en\/wp-json\/wp\/v2\/media?parent=90120"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.waseda.jp\/top\/en\/wp-json\/wp\/v2\/categories?post=90120"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.waseda.jp\/top\/en\/wp-json\/wp\/v2\/tags?post=90120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}